SR One Capital Fund I Aggregator LP 3
3 · Design Therapeutics, Inc. · Filed Mar 25, 2021
Insider Transaction Report
Form 3
SR One Capital Fund I Aggregator LP
10% Owner
Holdings
Series B Preferred Stock
→ Common Stock (936,637 underlying)Series A Preferred Stock
→ Common Stock (4,439,839 underlying)
Footnotes (2)
- [F1]All outstanding shares of Preferred Stock will automatically convert into shares of Common Stock at a rate of 1 share of Common Stock for each 1.63 shares of Preferred Stock, based on the conversion price currently in effect, at the Reporting Person's election and automatically upon the closing of the initial public offering of Design Therapeutics, Inc. (the "Issuer"). The Preferred Stock has no expiration date.
- [F2]The reported securities are held directly by SR One Capital Fund I Aggregator, LP. SR One Capital Partners I, LP is the general partner of SR One Capital Fund I Aggregator, LP, and SR One Capital Management, LLC is the general partner of SR One Capital Partners I, LP. Simeon George, M.D. is the managing member of SR One Capital Management, LLC. Each of SR One Capital Partners I, LP, SR One Capital Management, LLC and Mr. George may each be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.